FIBROBLAST GROWTH FACTOR 21: A POWERFUL THERAPEUTIC FOR HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS

被引：0
|
作者：
Liu, C. [1 ,2 ]
Schonke, M. [1 ,2 ]
Zhou, E. [1 ,2 ]
Li, Z. [1 ,2 ]
Kooijman, S. [1 ,2 ]
Larsson, M. [3 ]
Wallenius, K. [3 ]
Peng, X. -R. [3 ]
Wang, Y. [1 ,2 ,4 ]
Rensen, P. [1 ,2 ,4 ]
机构：
[1] Leiden Univ, Med Ctr, Div Endocrinol, Dept Med, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands
[3] AstraZeneca, Imed Biotech Unit, Cardiovasc Renal & Metab, Gothenburg, Sweden
[4] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China
来源：
ATHEROSCLEROSIS | 2020年 / 315卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
768
引用
收藏
页码：E16 / E17
页数：3
相关论文
共 50 条
  • [1] The role of fibroblast growth factor 21 in atherosclerosis
    Kokkinos, John
    Tang, Shudi
    Rye, Kerry-Anne
    Ong, Kwok Leung
    ATHEROSCLEROSIS, 2017, 257 : 259 - 265
  • [2] Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
    Kwok, Kelvin H. M.
    Lam, Karen S. L.
    ENDOCRINOLOGY AND METABOLISM, 2017, 32 (02) : 145 - 151
  • [3] FIBROBLAST GROWTH FACTOR 21 POTENTLY REDUCES ATHEROSCLEROSIS AND NASH DEVELOPMENT
    Liu, C.
    Schonke, M.
    Spoorenberg, B.
    Lambooij, J.
    Hendrik, V. D. Z.
    Zhou, E.
    Dekker, N.
    Andreasson, A-C
    Park, A.
    Uhrbom, M.
    Ahlstedt, I.
    Ikeda, Y.
    Wallenius, K.
    Peng, X-R
    Guigas, B.
    Boon, M.
    Wang, Y.
    Rensen, P.
    ATHEROSCLEROSIS, 2022, 355 : E74 - E75
  • [4] Therapeutic effects of fibroblast growth factor-21 against atherosclerosis via the NF-B pathway
    Zhang, Yiming
    Liu, Zhao
    Zhou, Min
    Liu, Changjian
    MOLECULAR MEDICINE REPORTS, 2018, 17 (01) : 1453 - 1460
  • [5] Effects of fibroblast growth factor 21 on cell damage in vitro and atherosclerosis in vivo
    Zhu, Wenhe
    Wang, Changwen
    Liu, Lei
    Li, Yan
    Li, Xiaokun
    Cai, Jianhui
    Wang, Huiyan
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2014, 92 (11) : 927 - 935
  • [6] Sex Modifies the Association of Fibroblast Growth Factor 21 With Subclinical Carotid Atherosclerosis
    Chee, Yingjie
    Toh, Grace Lx
    Lim, Chien Joo
    Goh, Liuh Ling
    Dalan, Rinkoo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [7] Fibroblast Growth Factor-21 as a Therapeutic Agent for Metabolic Diseases
    Alexei Kharitonenkov
    Armen B. Shanafelt
    BioDrugs, 2008, 22 : 37 - 44
  • [8] Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases
    Kharitonenkov, Alexei
    Shanafelt, Armen B.
    BIODRUGS, 2008, 22 (01) : 37 - 44
  • [9] Harnessing the Action of Fibroblast Growth Factor21 as a Therapeutic Agent
    Brunetti L.
    Kagan L.
    Current Pharmacology Reports, 2017, 3 (1) : 26 - 35
  • [10] Fibroblast growth factor 21
    Trusz, Guillaume J.
    DIFFERENTIATION, 2024, 139
12345